2,654
Views
27
CrossRef citations to date
0
Altmetric
LetterToEditor Article

Conventional vs. Liposomal Amphotericin B in Immunosuppressed Children

, , , , , & show all
Pages 187-190 | Received 06 Jun 1991, Accepted 16 Aug 1991, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Dimitrios Doganis, Margarita Baka, Apostolos Pourtsidis, Despina Bouhoutsou, Maria Varvoutsi, Georgios Stamos, Nikolaos Anastasiou, Emmanouel Androulakakis & Helen Vasilatou-Kosmidis. (2007) SUCCESSFUL COMBINATION OF ANTIFUNGAL AGENTS AND SURGICAL RESECTION FOR PULMONARY ASPERGILLOSIS IN A CHILD WITH HODGKIN DISEASE: Review of the Literature. Pediatric Hematology and Oncology 24:8, pages 631-638.
Read now
Rimma Melamed, Eugene Leibovitz, Oren Abramson, Aviva Levitas, Nili Zucker, Rafael Gorodisher. (2000) Successful Non-Surgical Treatment of Candida tropicalis Endocarditis with Liposomal Amphotericin-B (AmBisome). Scandinavian Journal of Infectious Diseases 32:1, pages 86-89.
Read now
Hans J. Dornbusch, Christian E. Urban, Hans Pinter, Gabriele Ginter, Richard Fotter, Hans Becker, Tillo Miorini & Christian Berghold. (1995) Treatment of Invasive Pulmonary Aspergillosis in Severely Neutropenic Children with Malignant Disorders using Liposomal Amphotericin B (AmBisome), Granulocyte Colony-Stimulating Factor, and Surgery: Report of Five Cases. Pediatric Hematology and Oncology 12:6, pages 577-586.
Read now
Jill P. Adler-moore & Richard T. Proffitt. (1993) Development, Characterization, Efficacy and Mode of Action of Ambisome, A Unilamellar Liposomal Formulation of Amphotericin B. Journal of Liposome Research 3:3, pages 429-450.
Read now

Articles from other publishers (23)

Helle Krogh Johansen & Peter C Gøtzsche. (2014) Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. Cochrane Database of Systematic Reviews 2017:3.
Crossref
K. K. Y. Wong & X. L. Liu. (2012) Nanomedicine: a primer for surgeons. Pediatric Surgery International 28:10, pages 943-951.
Crossref
S. Pancham, C. Hemmaway, H. New, E. Albert, I. Dokal, I. A. G. Roberts & M. McCloy. (2005) Caspofungin for invasive fungal infections: Combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. Pediatric Transplantation 9:2, pages 254-257.
Crossref
Romuald Bellmann, Petra Egger & Christian J. Wiedermann. (2003) Differences in Pharmacokinetics of Amphotericin B Lipid Formulations Despite Clinical Equivalence. Clinical Infectious Diseases 36:11, pages 1500-1501.
Crossref
J. Tollemar, L. Klingspor & O. Ringdén. (2001) Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children. Clinical Microbiology and Infection 7, pages 68-79.
Crossref
B. Steiner & M. Freund. 2001. Infektiologie Aktuelle Aspekte. Infektiologie Aktuelle Aspekte 11 18 .
Helle Krogh Johansen & Peter C Gøtzsche. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Axel Schmidt & Frank‐Ulrich Geschke. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Thomas Lehrnbecher, Andreas H. Groll & Stephen J. Chanock. (1999) Treatment of fungal infections in neutropenic children. Current Opinion in Pediatrics 11:1, pages 39-46.
Crossref
ALDA SCARCELLA, MARIA B. PASQUARIELLO, BRUNELLA GIUGLIANO, MARIA VENDEMMIA & AMALIA DE LUCIA. (1998) Liposomal amphotericin B treatment for neonatal fungal infections. The Pediatric Infectious Disease Journal 17:2, pages 146-148.
Crossref
Andreas H. Groll, Stephen C. Piscitelli & Thomas J. Walsh. 1998. 343 500 .
J. -H. Weitkamp, C. F. Poets, R. Sievers, E. Musswessels, P. Groneck, P. Thomas & P. Bartmann. (1998) Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome®). Infection 26:1, pages 11-15.
Crossref
Jill P. Adler-Moore & Richard T. Proffitt. 1998. Long Circulating Liposomes: Old Drugs, New Therapeutics. Long Circulating Liposomes: Old Drugs, New Therapeutics 185 206 .
K. Seel, C. Feiterna-Sperling & I. Grosch-Wörner. 1998. HIV und Aids. HIV und Aids 126 154 .
Christoph M. Tang & Ian C.J.W. Bowler. (1997) Do the new lipid formulations of amphotericin B really work?. Clinical Microbiology and Infection 3:3, pages 283-288.
Crossref
HARRY H. SHARATA & KENNETH H. KATZ. (2007) LIPOSOMES. International Journal of Dermatology 35:11, pages 761-769.
Crossref
Liisa Hovi, Ulla M. Saarinen, Ulla Donner & Christian Lindqvist. (1996) Opportunistic Osteomyelitis in the Jaws of Children on Immunosuppressive Chemotherapy. Journal of Pediatric Hematology/Oncology 18:1, pages 90-94.
Crossref
R.J.I. HITCHCOCK, A. PALLETT, M.A. HALL & P.S.J. MALONE. (2008) Urinary tract candidiasis in neonates and infants. British Journal of Urology 76:2, pages 252-256.
Crossref
P Chastagner, D Maillot, L Kures, J.L Georges, C Schmitt, P Bordigoni & D Sommelet. (1995) Évolution favorable d'une mucormycose orbitonasosinusienne compliquant le traitement d'induction d'une leucémie aiguë lymphoblastique. Archives de Pédiatrie 2:1, pages 47-51.
Crossref
M Sharland, R J Hay & E G Davies. (1994) Liposomal amphotericin B in hepatic candidosis.. Archives of Disease in Childhood 70:6, pages 546-547.
Crossref
R.J. Hay. (1994) Liposomal amphotericin B, AmBisome. Journal of Infection 28, pages 35-43.
Crossref
H.A. Leake, M.N. Appleyard & J.P.R. Hartley. (1994) Successful treatment of resistant cryptococcal meningitis with amphotericin B lipid emulsion after nephrotoxicity with conventional intravenous amphotericin B. Journal of Infection 28:3, pages 319-322.
Crossref
W. Emminger, W. Graninger, W. Emminger-Schmidmeier, A. Zoubek, K. Pillwein, M. Susani, A. Wasserer & H. Gadner. (1994) Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer. Annals of Hematology 68:1, pages 27-31.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.